0001209191-14-005682.txt : 20140129
0001209191-14-005682.hdr.sgml : 20140129
20140129194802
ACCESSION NUMBER: 0001209191-14-005682
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20140129
FILED AS OF DATE: 20140129
DATE AS OF CHANGE: 20140129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celladon Corp
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330971591
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 12760 HIGH BLUFF DRIVE
STREET 2: SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-366-4288
MAIL ADDRESS:
STREET 1: 12760 HIGH BLUFF DRIVE
STREET 2: SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUDY JEFFREY J
CENTRAL INDEX KEY: 0001590705
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 14558312
MAIL ADDRESS:
STREET 1: C/O CELLADON CORPORATION
STREET 2: 12760 HIGH BLUFF DRIVE, SUITE 240
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2014-01-29
0
0001305253
Celladon Corp
CLDN
0001590705
RUDY JEFFREY J
12760 HIGH BLUFF DRIVE, STE 240
SAN DIEGO
CA
92130
0
1
0
0
VP Clinical Operations
Stock option (right to buy)
212.33
2016-07-25
Common Stock
40
D
Stock option (right to buy)
224.82
2017-07-03
Common Stock
40
D
Stock option (right to buy)
224.82
2017-11-13
Common Stock
201
D
Stock option (right to buy)
224.82
2018-05-06
Common Stock
55
D
Stock option (right to buy)
224.82
2019-03-10
Common Stock
25
D
Stock option (right to buy)
224.82
2020-01-14
Common Stock
25
D
Stock option (right to buy)
349.72
2020-06-10
Common Stock
98
D
Stock option (right to buy)
1.12
2022-06-14
Common Stock
108354
D
Stock option (right to buy)
8.00
2024-01-28
Common Stock
30900
D
The stock options are fully vested and exercisable.
The shares subject to the option vest 1/48th per month beginning one month after April 27, 2010 (the "Vesting Commencement Date") and continue thereafter until the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly intallments thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
25% of the shares subject to the option shall vest on the one year anniversary of January 29, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly intallments thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
/s/ Rebecque Laba, Attorney-in-fact
2014-01-29
EX-24.3_503782
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and appoints
each of, Krisztina M. Zsebo, Rebecque J. Laba and Fredrik Wiklund of Celladon
Corporation (the "Company"), signing individually, the undersigned's true and
lawful attorney-in fact and agent to:
(1) execute for and on behalf of the undersigned, an officer, director or holder
of 10% of more of a registered class of securities of the Company, Forms 3, 4
and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act") and the rules thereunder;
(2) do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to complete and execute such Form 3, 4 or 5,
complete and execute any amendment or amendments thereto, and timely file such
forms or amendments with the United States Securities and Exchange Commission
and any stock exchange or similar authority; and
(3) take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in
the best interest of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
The undersigned hereby grants to such attorney-in-fact full power and authority
to do and perform any and every act and thing whatsoever requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorney-in-fact, in
serving in such capacity at the request of the undersigned, is not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect until the earliest
to occur of (a) the undersigned is no longer required to file Forms 3, 4 and 5
with respect to the undersigned's holdings of and transactions in securities
issued by the Company, (b) revocation by the undersigned in a signed writing
delivered to the foregoing attorney-in-fact or (c) until such attorney-in-fact
shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 13th day of November, 2013.
/s/ Jeffrey J. Rudy
Jeffrey J. Rudy